Clinical Trial Update: the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis

View source ↗

Summary

This update reports on the long-term retention rate of Vedolizumab for ulcerative colitis and examines factors that influence its ongoing use in individualized …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: IBD (Inflammatory Bowel Disease) | Status: COMPLETED